IBD Predicts Cognitive Loss — and Vice Versa – in Seniors

Published Date: 04 Mar 2026

Active IBD in older adults is linked to higher odds of cognitive decline over 1 year, and deficits in delayed recall signal an increased risk for active disease.

Read Full News

Latest News

Sexual Desire in Menopause May Reflect Psychosocial Factors

Evidence suggests that sexual function may remain stable or improve after menopause, challenging assumptions of decline.

Cholecystectomy Outcomes Improve Despite Patient Complexity

Among Medicare inpatients who undergo minimally invasive cholecystectomy, the rates of overall and serious complications decline over a decade.

FDA Marks hopes to act as global regulator to promote gene therapy

FDA Director Peter Marks said Wednesday he hopes to harmonize international regulations to encourage the commercialization of gene and cell therapies to bring more treatments to market for patients with rare diseases.

Age-Specific Needs in Young Women With Breast Cancer

Drs Olivia Pagani and Ann Partridge discuss how to optimize the care plan for young patients with breast cancer, focusing on age-specific concerns such as fertility and long-term survivorship.

Beyond Hot Flash: Shared Decision-Making in Menopause

A gynecologist and a patient advocate share strategies for alerting patients to the spectrum of menopause symptoms and engaging them in shared decision-making to improve quality of life.

Air Pollution Linked to Reduced Midlife Cognitive Function

Everyday exposure to traffic, industry, and wildfire smoke was associated with vascular brain injury in middle age.

Todays Updates

EMA Backs Breast Cancer SERD After FDA No Vote

The recommendation follows phase 3 data showing longer progression-free survival when patients switched to camizestrant plus a CDK4/6 inhibitor.

Datopotamab Deruxtecan Earns New Breast Cancer Indication

The antibody drug conjugate was approved by the FDA for certain patients with triple-negative breast cancer.

Todays Updates

EMA Backs Breast Cancer SERD After FDA No Vote

The recommendation follows phase 3 data showing longer progression-free survival when patients switched to camizestrant plus a CDK4/6 inhibitor.

Datopotamab Deruxtecan Earns New Breast Cancer Indication

The antibody drug conjugate was approved by the FDA for certain patients with triple-negative breast cancer.

Latest News

Evidence suggests that sexual function may remain stable or improve after menopause, challenging assumptions of decline.

Among Medicare inpatients who undergo minimally invasive cholecystectomy, the rates of overall and serious complications decline over a decade.

FDA Director Peter Marks said Wednesday he hopes to harmonize international regulations to encourage the commercialization of gene and cell therapies to bring more treatments to market for patients with rare diseases.

Drs Olivia Pagani and Ann Partridge discuss how to optimize the care plan for young patients with breast cancer, focusing on age-specific concerns such as fertility and long-term survivorship.

A gynecologist and a patient advocate share strategies for alerting patients to the spectrum of menopause symptoms and engaging them in shared decision-making to improve quality of life.

Everyday exposure to traffic, industry, and wildfire smoke was associated with vascular brain injury in middle age.

News All Time

Rapid Microbe Testing Does Not Cut Antibiotic Prescribing

Rapid microbiological point-of-care testing for respiratory tract infections does not reduce overall same-day antibiotic prescribing in primary care, a recent study shows.

Sleep Apnea Control Persists for Some After Stopping Device

Standard treatment for obstructive sleep apnea has long relied on continuous positive airway pressure machines, but new research suggests that for some, the issue is simply a matter of body position.

Fluid After Kidney Stones: Some Good, More Better

Analysis of data from the PUSH randomized trial affirmed that more fluid increase is better, but some still helps.

Creatinine Muscle Index May Predict Muscle Mass Loss

Creatinine muscle index can serve as a blood biomarker to estimate low muscle mass and identify individuals at an increased risk for frailty, comorbidities, and mortality.

New Licensing Route Could Speed Rare Disease Drug Access

A proposed MHRA framework would combine clinical trial and marketing authorisation approval, potentially cutting years from drug development.

Spain’s Debate Over Obstetric Violence

Health leaders in Spain debate balancing maternal-fetal safety with respectful, informed care, spotlighting birth plans, staffing shortages and calls for public outcome reporting.

Bayer Says FDA Grants Priority Review Designation for Finerenone

Bayer said on Thursday ⁠that the U.S. Food and ⁠Drug Administration had accepted its ⁠supplemental New ‌Drug Application for finerenone and granted priority review...

BioMarin's Drug Shows Significant Growth Gains in Children in Late-stage Trial

BioMarin Pharmaceutical said on Wednesday its treatment for a rare condition that ⁠leads to short stature helped boost growth in children, meeting the main goal of a...

Diabetic Peripheral Neuropathy Tied to Dementia Risk in T2D

Diabetic peripheral neuropathy above a certain vibration perception threshold is linked to a notably higher risk for dementia in patients with type 2 diabetes, according to a Danish cohort study.

Emerging Technology More Accurate Than FS in Mohs Study

Two-photon fluorescence microscopy has greater specificity, and noninferiority in sensitivity than frozen sections, suggesting a way to reduce taking unnecessary stages in Mohs surgery.

Many Patients Seeking Skin Cancer Screening Are Low Risk

Older age, lighter skin phototypes, and personal skin cancer history are linked to higher skin cancer detection rates during routine skin examinations, study shows.

Eating for One: The Future of Personalized Nutrition

Nutrition science is closing in on truly personalized dietary advice. The bigger challenge? Making sure it does not only land on wealthy plates.

Baxdrostat Approval May Open Doors for HTN Therapy

The FDA’s recent approval of baxdrostat may usher in new possibilities for treatment for uncontrolled hypertension.

Lentigo Maligna Rarely Progresses Despite Rising Incidence

Despite rising cases in recent years, lentigo maligna shows minimal progression to melanoma, and patients with this condition are more likely to die due to other factors, a retrospective study finds.

Prior Auth Rules Vary Widely Across Insurers, Study Finds

A new study finds that prior authorization requirements vary widely across major insurers and suggests large language models could help streamline how authorization rules are interpreted and processed.

Is Hypertension Undertreated in Pediatrics?

Long-term implications may be underestimated, and new data show relatively low medication use.

Recommended News For You

November 2023, Medical Bulletin 04/.

Data-driven risk stratification guides childhood brain tumor treatment, reducing side effects

FDA Bans Red Dye No. 3 From Foods, Ingested Drugs

Prostate cancer mortality is significantly reduced when docetaxel is used.

Hair Growth After Cancer; 'Global' Early-Onset CRC; Retifanlimab Boosts OS in NSCLC

Gene therapy for glioblastoma is effectively created by researchers.

New imaging solution could help improve survival for patients with recurring prostate cancer

Recommended Articles For You

Unlocking the Key to Treating Lymphoma: New Innovations in Cancer Research 

Ultimate Guide to Oncology Services in the USA 

Biomimetic Nanovesicles for Breast Cancer: Targeting Senescence to Overcome Chemoresistance 

Seeing the Unseen: The Benefits of Early Stage Breast Cancer Ultrasound 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Year in Review: Chronic Lymphocytic Leukemia

2.

According to a study, white Americans are overdiagnosing melanoma at an alarming rate.

3.

Approval in Endometrial Cancer Expanded; Masks at Cancer Centers; NPR Reporter Dies

4.

The First Gene Therapy Provides a Durable Response for Non-Muscle-Invasive Bladder Cancer.

5.

Canine Cancer Vaccine: A Potential Resurrection? U.S. KK. Snubs Enertu.

1.

What Is Carboxyhemoglobin And How Can It Affect Your Health?

2.

Lu-177 Vipivotide in Prostate Cancer: A Breakthrough in Radioligand Therapy

3.

Unraveling the Mysteries of Coagulopathy: A Comprehensive Definition

4.

Machine Learning in Genomic Analysis for Early Lung Cancer Detection: Key Advances and Insights

5.

A New Perspective on Spherocytosis: Uncovering Innovative Treatments

1.

International Lung Cancer Congress®

2.

Genito-Urinary Oncology Summit 2026

3.

Future NRG Oncology Meeting

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part II

2.

Navigating the Complexities of Ph Negative ALL - Part XIII

3.

Updates on the First Line Management of ALK+ NSCLC

4.

Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part IV

5.

Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part II

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot